• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Growth Hormone Releasing Factor, bovine

Growth Hormone Releasing Factor, bovine

Product ID G2871
Cas No. 88894-91-1
Purity ≥95%
Product Unit SizeCostQuantityStock
0.5 mg $415.70 Please Inquire
1 mg $661.00 Please Inquire
2.5 mg $1,328.80 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Growth hormone releasing factor (GHRF or GHRH) is an endogenous peptide hormone that binds the GHRH receptor in the anterior pituitary, inducing the release of growth hormone. GHRF promotes non-REM slow wave sleep in animal models. Additionally, GHRF decreases fat synthesis in adipose tissue in vivo, and increases locomotor activity in other animal models. In granulosa cells, GHRF stimulates activity of plasminogen activator, playing a role in follicular development.

Product Info

Cas No.

88894-91-1

Purity

≥95%

Formula

C220H366N72O66S

Formula Wt.

5107.88

Synonym

GHRF, GHRH

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

G2871 MSDS PDF

Info Sheet

G2871 Info Sheet PDF

References

Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • F5968

    Foretinib

    ROS1, MET, Ron, Axl, TIE-2, VEGFR2 inhibitor.

    ≥98%
  • B022691

    Baricitinib

    Selective and reversible JAK inhibitor.

    ≥99%
  • N1983

    Neuropeptide Y (3-36), human

    Endogenous peptide neurotransmitter, involved i...

    ≥95%
  • V1854

    Venlafaxine Hydrochloride

    SERT, NET, MAO inhibitor.

    ≥98%
  • R2815

    Recombinant HIV-1 “0” group consensus

    Recombinant HIV-1 antigen fragment.

    ≥95%
  • S041001

    SB-202190

    Highly selective inhibitor

    ≥99%
  • U6901

    Uracil

    Endogenous pyrimidine base required for product...

    ≥98%
  • D1770

    Dermorphin Analog

    Synthetic peptide; dermorphin analog; δOR and ...

    ≥95%
  • R3347

    Riluzole

    Benzothiazole; TRPC5 agonist, PTR1 inhibitor, v...

    ≥98%
  • M1644

    Meloxicam

    NSAID; COX-2 inhibitor.

    ≥98%
  • D004098

    Dacomitinib Anhydrous

    EGFR inhibitor.

    ≥99%
  • C9615

    Cyclosporin B

    Cyclic peptide; calcineurin inhibitor.

    ≥95%
  • R2788

    RGW-611

    Morpholine derivative.

    ≥98%
  • C0824

    CCG1423

    Serum response factor inhibitor and MRTF-A bind...

    ≥98%
  • L9874

    L-(+)-Lysine Monohydrate

    Non-endogenous essential amino acid found in me...

    ≥95%
  • S8012

    [Sar9]-Substance P

    Endogenous tachykinin peptide, involved in infl...

    ≥95%
  • P3540

    PIK-75 Hydrochloride

    p110α PI3K inhibitor.

    ≥98%
  • M400220

    MK-2206 Dihydrochloride

    Akt inhibitor.

    ≥99%
  • G8101

    Guaifenesin

    Expectorant.

    ≥98%
  • O4578

    Oltipraz

    Antioxidant; Nrf2 activator.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only